Literature DB >> 23473794

Plasma phospholipid saturated fatty acids and heart failure risk in the Physicians' Health Study.

Chisa Matsumoto1, Naomi Q Hanson, Michael Y Tsai, Robert J Glynn, J Michael Gaziano, Luc Djoussé.   

Abstract

BACKGROUND & AIMS: Previous studies have suggested that some plasma phospholipid saturated fatty acids (SFA) are associated with an increased risk of coronary heart disease and hypertension, major risk factors for heart failure (HF). However, little is known about the association between SFA and HF. This study examines associations of individual plasma phospholipid SFA with HF risk in US male physicians.
METHODS: The current ancillary study used a prospective nested matched case-control design to select 788 cases of incident HF and 788 controls. Plasma phospholipid SFAs were measured using gas chromatography. HF was self-reported on follow-up questionnaires and validated by review of medical records in a subsample. We used conditional logistic regression to estimate relative risks.
RESULTS: Mean age was 58.7 ± 8.0 years. One standard deviation higher plasma phospholipid 16:0 was associated with an odds ratio (95% CI) of 1.20 (1.04, 1.38) controlling for established HF risk factors and other SFAs (p = 0.042). However, this association was not significant after Bonferroni correction (p > 0.008). We did not observe associations between other SFAs (14:0, 15:0, 18:0, 20:0, or 22:0) and HF risk (all p for trend > 0.05).
CONCLUSIONS: Our data suggested no association between plasma phospholipid SFAs and HF in US male physicians.
Copyright © 2013 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  Heart failure; Palmitic acid; Saturated fatty acids

Mesh:

Substances:

Year:  2013        PMID: 23473794      PMCID: PMC3703479          DOI: 10.1016/j.clnu.2013.02.006

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  17 in total

1.  Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Authors:  Wayne Rosamond; Katherine Flegal; Gary Friday; Karen Furie; Alan Go; Kurt Greenlund; Nancy Haase; Michael Ho; Virginia Howard; Brett Kissela; Bret Kissela; Steven Kittner; Donald Lloyd-Jones; Mary McDermott; James Meigs; Claudia Moy; Graham Nichol; Christopher J O'Donnell; Veronique Roger; John Rumsfeld; Paul Sorlie; Julia Steinberger; Thomas Thom; Sylvia Wasserthiel-Smoller; Yuling Hong
Journal:  Circulation       Date:  2006-12-28       Impact factor: 29.690

2.  Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids.

Authors:  Jing Cao; Kerry A Schwichtenberg; Naomi Q Hanson; Michael Y Tsai
Journal:  Clin Chem       Date:  2006-10-19       Impact factor: 8.327

3.  Plasma fatty acid composition and 6-year incidence of hypertension in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Z J Zheng; A R Folsom; J Ma; D K Arnett; P G McGovern; J H Eckfeldt
Journal:  Am J Epidemiol       Date:  1999-09-01       Impact factor: 4.897

Review 4.  Design of Physicians' Health Study II--a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials.

Authors:  W G Christen; J M Gaziano; C H Hennekens
Journal:  Ann Epidemiol       Date:  2000-02       Impact factor: 3.797

5.  Final report on the aspirin component of the ongoing Physicians' Health Study.

Authors: 
Journal:  N Engl J Med       Date:  1989-07-20       Impact factor: 91.245

6.  Relation between modifiable lifestyle factors and lifetime risk of heart failure.

Authors:  Luc Djoussé; Jane A Driver; J Michael Gaziano
Journal:  JAMA       Date:  2009-07-22       Impact factor: 56.272

7.  Effects of a high saturated fat diet on cardiac hypertrophy and dysfunction in response to pressure overload.

Authors:  David J Chess; Biao Lei; Brian D Hoit; Agnes M Azimzadeh; William C Stanley
Journal:  J Card Fail       Date:  2008-02       Impact factor: 5.712

8.  Plasma fatty acid composition and incident heart failure in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Kazumasa Yamagishi; Jennifer A Nettleton; Aaron R Folsom
Journal:  Am Heart J       Date:  2008-08-29       Impact factor: 4.749

9.  Serum fatty acids and the risk of coronary heart disease.

Authors:  J A Simon; M L Hodgkins; W S Browner; J M Neuhaus; J T Bernert; S B Hulley
Journal:  Am J Epidemiol       Date:  1995-09-01       Impact factor: 4.897

Review 10.  Dietary carbohydrate restriction induces a unique metabolic state positively affecting atherogenic dyslipidemia, fatty acid partitioning, and metabolic syndrome.

Authors:  Jeff S Volek; Maria Luz Fernandez; Richard D Feinman; Stephen D Phinney
Journal:  Prog Lipid Res       Date:  2008-03-15       Impact factor: 16.195

View more
  6 in total

1.  Association between plasma phospholipid saturated fatty acids and metabolic markers of lipid, hepatic, inflammation and glycaemic pathways in eight European countries: a cross-sectional analysis in the EPIC-InterAct study.

Authors:  Ju-Sheng Zheng; Stephen J Sharp; Fumiaki Imamura; Albert Koulman; Matthias B Schulze; Zheng Ye; Jules Griffin; Marcela Guevara; José María Huerta; Janine Kröger; Ivonne Sluijs; Antonio Agudo; Aurelio Barricarte; Heiner Boeing; Sandra Colorado-Yohar; Courtney Dow; Miren Dorronsoro; Pia T Dinesen; Guy Fagherazzi; Paul W Franks; Edith J M Feskens; Tilman Kühn; Verena Andrea Katzke; Timothy J Key; Kay-Tee Khaw; Maria Santucci de Magistris; Francesca Romana Mancini; Elena Molina-Portillo; Peter M Nilsson; Anja Olsen; Kim Overvad; Domenico Palli; Jose Ramón Quirós; Olov Rolandsson; Fulvio Ricceri; Annemieke M W Spijkerman; Nadia Slimani; Giovanna Tagliabue; Anne Tjonneland; Rosario Tumino; Yvonne T van der Schouw; Claudia Langenberg; Elio Riboli; Nita G Forouhi; Nicholas J Wareham
Journal:  BMC Med       Date:  2017-11-17       Impact factor: 8.775

2.  Serial Biomarkers of De Novo Lipogenesis Fatty Acids and Incident Heart Failure in Older Adults: The Cardiovascular Health Study.

Authors:  Yujin Lee; Heidi T M Lai; Marcia C de Oliveira Otto; Rozenn N Lemaitre; Barbara McKnight; Irena B King; Xiaoling Song; Gordon S Huggins; Amanda R Vest; David S Siscovick; Dariush Mozaffarian
Journal:  J Am Heart Assoc       Date:  2020-02-05       Impact factor: 5.501

Review 3.  Very long-chain saturated fatty acids and diabetes and cardiovascular disease.

Authors:  Rozenn N Lemaitre; Irena B King
Journal:  Curr Opin Lipidol       Date:  2022-02-01       Impact factor: 4.616

4.  Plasma phospholipid saturated fatty acids and incident atrial fibrillation: the Cardiovascular Health Study.

Authors:  Amanda M Fretts; Dariush Mozaffarian; David S Siscovick; Luc Djousse; Susan R Heckbert; Irena B King; Barbara McKnight; Colleen Sitlani; Frank M Sacks; Xiaoling Song; Nona Sotoodehnia; Donna Spiegelman; Erin R Wallace; Rozenn N Lemaitre
Journal:  J Am Heart Assoc       Date:  2014-06-26       Impact factor: 5.501

5.  Dietary Very Long Chain Saturated Fatty Acids and Metabolic Factors: Findings from the Korea National Health and Nutrition Examination Survey 2013.

Authors:  Youn Sue Lee; Yoonsu Cho; Min-Jeong Shin
Journal:  Clin Nutr Res       Date:  2015-07-31

6.  Associations of Plasma Phospholipid SFAs with Total and Cause-Specific Mortality in Older Adults Differ According to SFA Chain Length.

Authors:  Amanda M Fretts; Dariush Mozaffarian; David S Siscovick; Irena B King; Barbara McKnight; Bruce M Psaty; Eric B Rimm; Colleen Sitlani; Frank M Sacks; Xiaoling Song; Nona Sotoodehnia; Donna Spiegelman; Rozenn N Lemaitre
Journal:  J Nutr       Date:  2015-12-23       Impact factor: 4.798

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.